FdaApplication
NDA 020229
Identifiers
- fda_app_no: NDA020229
Properties
| Property | Value |
|---|---|
| applicant_name | JANSSEN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1993-02-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEUSTATIN | CLADRIBINE | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
1 product